Literature DB >> 10821955

In vivo selection of sFv from phage display libraries.

M Johns1, A J George, M A Ritter.   

Abstract

The development of phage display technology has facilitated the development of many new and sometimes novel antibody based reagents for scientific research. However, present methods for selection from phage-sFv display libraries are limited to selection against purified antigens or ex vivo cells of known origin and phenotype. Existing methods therefore preclude the isolation of sFv against unknown molecules in their natural environment, where expression is complex and subject to diverse control mechanisms. Since such a complex environment is difficult to mimic in vitro, the development of an in vivo selection procedure would greatly enhance the selection from phage display antibody libraries and lead to the development of reagents against cell surface molecules in their natural environment. This would be particularly advantageous for isolation of sFv against vascular endothelium which can readily change phenotype when cultured and is believed to express molecules in a tissue specific manner and in response to different stimuli. We describe here the development of an in vivo selection procedure in the mouse and demonstrate its potential for the selection of sFv from a phage-sFv library. The target antigen for one sFv is expressed solely on the thymic endothelium, while the second, a 165-170 kDa molecule in present on both thymic endothelium and the perivascular epithelium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10821955     DOI: 10.1016/s0022-1759(00)00152-6

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

1.  Preparation of single chain variable fragment of MG(7) mAb by phage display technology.

Authors:  Z C Yu; J Ding; Y Z Nie; D M Fan; X Y Zhang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

2.  Expression and bioactivity identification of soluble MG7 scFv.

Authors:  Zhao-Cai Yu; Jie Ding; Bo-Rong Pan; Dai-Ming Fan; Xue-Yong Zhang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

Review 3.  Phage display: practicalities and prospects.

Authors:  William G T Willats
Journal:  Plant Mol Biol       Date:  2002-12       Impact factor: 4.076

4.  Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies.

Authors:  David Sánchez-Martín; Jorge Martínez-Torrecuadrada; Tambet Teesalu; Kazuki N Sugahara; Ana Alvarez-Cienfuegos; Pilar Ximénez-Embún; Rodrigo Fernández-Periáñez; M Teresa Martín; Irene Molina-Privado; Isabel Ruppen-Cañás; Ana Blanco-Toribio; Marta Cañamero; Angel M Cuesta; Marta Compte; Leonor Kremer; Carmen Bellas; Vanesa Alonso-Camino; Irene Guijarro-Muñoz; Laura Sanz; Erkki Ruoslahti; Luis Alvarez-Vallina
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-05       Impact factor: 11.205

Review 5.  Current state of in vivo panning technologies: Designing specificity and affinity into the future of drug targeting.

Authors:  Heather H Gustafson; Audrey Olshefsky; Meilyn Sylvestre; Drew L Sellers; Suzie H Pun
Journal:  Adv Drug Deliv Rev       Date:  2018-06-28       Impact factor: 15.470

Review 6.  T7 Phage as an Emerging Nanobiomaterial with Genetically Tunable Target Specificity.

Authors:  Hui Yue; Yan Li; Mingying Yang; Chuanbin Mao
Journal:  Adv Sci (Weinh)       Date:  2021-12-16       Impact factor: 16.806

Review 7.  High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand.

Authors:  Nicola Zambrano; Guendalina Froechlich; Dejan Lazarevic; Margherita Passariello; Alfredo Nicosia; Claudia De Lorenzo; Marco J Morelli; Emanuele Sasso
Journal:  Cancers (Basel)       Date:  2022-03-04       Impact factor: 6.639

Review 8.  In vivo Phage Display: A promising selection strategy for the improvement of antibody targeting and drug delivery properties.

Authors:  Ana S André; Isa Moutinho; Joana N R Dias; Frederico Aires-da-Silva
Journal:  Front Microbiol       Date:  2022-09-26       Impact factor: 6.064

9.  By-passing large screening experiments using sequencing as a tool to identify scFv fragments targeting atherosclerotic lesions in a novel in vivo phage display selection.

Authors:  Kamel Deramchia; Marie-Josee Jacobin-Valat; Jeanny Laroche-Traineau; Stephane Bonetto; Stephane Sanchez; Pierre Dos Santos; Philippe Massot; Jean-Michel Franconi; Pierre Martineau; Gisele Clofent-Sanchez
Journal:  Int J Mol Sci       Date:  2012-06-07       Impact factor: 6.208

Review 10.  T4 bacteriophage as a phage display platform.

Authors:  Mariam Gamkrelidze; Krystyna Dąbrowska
Journal:  Arch Microbiol       Date:  2014-05-15       Impact factor: 2.552

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.